You might’ve read my latest blog post of how GVBP simply recycles the old press releases and has the same executives of the failure Nextgen Biosciences, but there’s more…
Yes, I’m short 30,000 shares of GVBP so it’s in my interest to dig up dirt on GVBP, but this isn’t even about making $ anymore, it’s infinitely more fun/interesting to expose GVBP’s web of lies and manipulation and the dirt is EVERYWHERE. So check out what I found:
NextGen Biosciences (NXGB) last traded at .007 cants/share, but as reported by Businessweek, they changed their name to Kalahari Greentech Inc last December and gave up on the whole cancer cure charade to focus on energy, as CEO Konstantinos Kardiasmenos reported on their website.
Why would Nextgen give up on their cancer cure attempts, after all, they had control of the EXACT 3 patents that GVBP is hyping so much!!!! That’s right kiddies, GVBP’s 3 patents which they bought for $75,000 cash, as listed on page 9 of this SEC filing, and at Friday’s closing price have a value of $160 million+:
Use of prostaganin for treatment of prostate cancer
Use of tetanolic acid for treatment of breast cancer
Method for inducing breast carcinoma stem cell death
…are the SAME ones owned by Nextgen, before Nextgen gave up on them…You can see the 2 cancer compounds in on page F-11 in THIS SEC filing and the stem cell one Nextgen acquired as reported in this PR.
And guess what NextGen’s address was:
4th Floor, 36 Spital Square, London, E1 6DY, England
Yup, that’s the EXACT same address as GVBP’s alleged partners, as I wrote about in this blog post, Prime Bioresearch & Bridge Bio (oh wait, as I covered in this post, Bridge backed out late Friday LOL)
I know this can get confusing, but let’s recap: GVBP’s $160+ million marketcap has been built on stock promoters hyping up the “potential” for its 3 cancer/stem cell patents. Unofortunately, they’ve been using recycled press releases and the patents of the failure NextGen and passing them off as something new and exciting.
Besides earning $15,000ish if and when GVBP’s stock gets halted by the SEC (as should happen, but there’s now ay to know if/when the SEC will act) and the stock goes to 0, I think I might earn some kind of journalism award for piecing this Enron-esque thing together so quickly.
It’s your duty to learn to profit from pump & dumps like GVBP…legally…as I’ve made millions on shorting nasty conflicting penny stocks…these study guides help…this isn’t rocket science, but you do need to know the basics.
Posted in Manipulation